Read news on Zepbound with our app.
Read more in the app
New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound
The weight-loss drugs on trial in 2026 may trump Ozempic and Zepbound
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports
Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study
Highly effective weight-loss drug Zepbound approved in the US and UK
Highly effective weight-loss drug Zepbound approved for use in the US
